Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Operating Expenses (2016 - 2025)

Mimedx (MDXG) has disclosed Operating Expenses for 15 consecutive years, with $77.8 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 358.55% to $77.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $233.4 million through Dec 2025, up 277.29% year-over-year, with the annual reading at $281.3 million for FY2025, 354.68% up from the prior year.
  • Operating Expenses hit $77.8 million in Q4 2025 for Mimedx, up from $72.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $77.8 million in Q4 2025 to a low of -$106.1 million in Q4 2022.
  • Historically, Operating Expenses has averaged $39.9 million across 5 years, with a median of $55.6 million in 2022.
  • Biggest five-year swings in Operating Expenses: tumbled 327.15% in 2022 and later skyrocketed 394.15% in 2025.
  • Year by year, Operating Expenses stood at $46.7 million in 2021, then crashed by 327.15% to -$106.1 million in 2022, then surged by 153.51% to $56.8 million in 2023, then plummeted by 70.11% to $17.0 million in 2024, then skyrocketed by 358.55% to $77.8 million in 2025.
  • Business Quant data shows Operating Expenses for MDXG at $77.8 million in Q4 2025, $72.7 million in Q3 2025, and $19.6 million in Q2 2025.